MedPath

Intralesional steroid injections to prevent refractory strictures in patients with esophageal atresia - a randomized controlled trial

Phase 3
Recruiting
Conditions
narrowing esophagus
stricture after esophageal atresia
10018008
Registration Number
NL-OMON50430
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

- Children with EA type C who underwent primary anastomotic surgery
- Age >=3 months at the time of the 3rd dilatation
- In need of a 3rd dilatation
- Written informed consent by both parents or guardians if applicable

Exclusion Criteria

- Age <3 months
- Known inability from previous dilatations to use an endoscope with a size of
5.8 mm
- No parental written informed consen

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary outcome parameter is the total number of dilatations within 28 days<br /><br>interval needed per patient during the study period, i.e. from the day of the<br /><br>3rd dilatation until 6 months later. </p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath